A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer

Clinical trial NCT02151084 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02151084
Sponsor: University Health Network, Toronto
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Carcinoma Gallbladder Carcinoma

Start date: 2014-11-01
Primary completion: 2027-05-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.